Anti-inflammatory effect of curcumin on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse

Cellular Immunology

Volumn 298, Issue 1-2, 2015, Pages 88-95

  Zhang, Ning ^a   Li, Hong ^a   Jia, Jihui ^b   He, Mingqiang ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Allergic rhinitis; Anti inflammatory; Curcumin; Ovalbumin

Indexed keywords

ANTIINFLAMMATORY AGENT; CURCUMIN; CYTOKINE; HISTAMINE; I KAPPA B; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OVALBUMIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; IL1B PROTEIN, MOUSE; NF-KAPPAB INHIBITOR ALPHA;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; FEMALE; HEART MUSCLE; HISTAMINE RELEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAST CELL; MOUSE; NONHUMAN; NOSE MUCOSA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SNEEZING; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; RHINITIS, ALLERGIC; SECRETION (PROCESS);

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CURCUMIN; FEMALE; HISTAMINE; HISTAMINE RELEASE; HUMANS; I-KAPPA B PROTEINS; IMMUNOGLOBULIN E; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; NASAL MUCOSA; OVALBUMIN; OXIDATIVE STRESS; RHINITIS, ALLERGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84959345618     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.09.010     Document Type: Article

References (32)

1. Lee N.P., Arriola E.R. How to treat allergic rhinitis. West. J. Med. 1999, 171:31-34.
2. Mandhane S.N., Shah J.H., Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int. Immunopharmacol. 2011, 11:1646-1662.
3. Dykewicz M.S., Fineman S., Skoner D.P. Joint task force summary statements on diagnosis and management of rhinitis. Ann. Allergy Asthma Immunol. 1998, 81:474-477.
4. Prenner B.M., Schenkel E. Allergic rhinitis: treatment based on patient profiles. Am. J. Med. 2006, 119:230-237.
5. Quraishi S.A., Davies M.J., Craig T.J. Inflammatory responses in allergic rhinitis: traditional approaches and novel treatment strategies. J. Am. Osteopath. Assoc. 2004, 104:S7-S15.
6. Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 1991, 57:1-7.
7. Ju H.R., Wu H.Y., Nishizono S., Sakono M., Ikeda I., Sugano M., Imaizumi K. Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats. Biosci. Biotechnol. Biochem. 1996, 60:1856-1860.
8. Kurup V.P., Barrios C.S. Immunomodulatory effects of curcumin in allergy. Mol. Nutr. Food Res. 2008, 52:1031-1039.
9. Kurup V.P., Barrios C.S., Raju R., Johnson B.D., Levy M.B., Fink J.N. Immune response modulation by curcumin in a latex allergy model. Clin. Mol. Allergy 2007, 5:1.
10. Naik S.R., Thakare V.N., Patil S.R. Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property. Exp. Toxicol. Pathol. 2011, 63:419-431.
11. Suzuki M., Nakamura T., Iyoki S., Fujiwara A., Watanabe Y., Mohri K., Isobe K., Ono K., Yano S. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol. Pharm. Bull. 2005, 28:1438-1443.
12. Lee J.H., Kim J.W., Ko N.Y., Mun S.H., Her E., Kim B.K., Han J.W., Lee H.Y., Beaven M.A., Kim Y.M., Choi W.S. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J. Allergy Clin. Immunol. 2008, 121:1225-1231.
13. Vojdani A., Erde J. Regulatory T cells, a potent immunoregulatory target for CAM researchers: the ultimate antagonist. Evid. Based Complement. Altern. Med. 2006, 3:25-30.
14. Kim do K., Kim H.S., Kim A.R., Kim J.H., Kim B., Noh G., Kim H.S., Beaven M.A., Kim Y.M., Choi W.S. DJ-1 regulates mast cell activation and IgE-mediated allergic responses. J. Allergy Clin. Immunol. 2013, 131:1653-1662.
15. Cho M.S., Park W.S., Jung W.K., Qian Z.J., Lee D.S., Choi J.S., Lee D.Y., Park S.G., Seo S.K., Kim H.J., Won J.Y., Yu B.C., Choi I.W. Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-kappaB signaling in activated HMC-1 human mast cells. Pharm. Biol. 2014, 52:926-932.
16. Won Jung H., Jung J.K., Weon Cho C., Kang J.S., Park Y.K. Antiallergic effect of KOB03, a polyherbal medicine, on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse and human mast cells. J. Ethnopharmacol. 2012, 142:684-693.
17. Fu L.J., Dai Y., Wang Z.T., Zhang M. Inhibition of experimental allergic rhinitis by the n-butanol fraction from the anomalous fruits of Gleditsia sinensis. Biol. Pharm. Bull. 2003, 26:974-977.
18. Bahekar P.C., Shah J.H., Ayer U.B., Mandhane S.N., Thennati R. Validation of guinea pig model of allergic rhinitis by oral and topical drugs. Int. Immunopharmacol. 2008, 8:1540-1551.
19. Thakare V.N., Osama M.M., Naik S.R. Therapeutic potential of curcumin in experimentally induced allergic rhinitis in guinea pigs. Int. Immunopharmacol. 2013, 17:18-25.
20. Min Y.G. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol. Res. 2010, 2:65-76.
21. Smith L.J. Pharmacology and safety of the leukotriene antagonists. Clin. Rev. Allergy Immunol. 1999, 17:195-212.
22. Church M.K., Levi-Schaffer F. The human mast cell. J. Allergy Clin. Immunol. 1997, 99:155-160.
23. Nugroho A.E., Ikawati Z., Sardjiman, Maeyama K. Effects of benzylidenecyclopentanone analogues of curcumin on histamine release from mast cells. Biol. Pharm. Bull. 2009, 32:842-849.
24. Grzelewska-Rzymowska I., Pietrzkowicz M. Role of tumor necrosis factor-alpha in allergic inflammation and airway hyperresponsiveness. Pol. Merkur. Lekarski. 2004, 16:173-178.
25. Bradding P., Feather I.H., Wilson S., Bardin P.G., Heusser C.H., Holgate S.T., Howarth P.H. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 1993, 151:3853-3865.
26. Bradding P., Mediwake R., Feather I.H., Madden J., Church M.K., Holgate S.T., Howarth P.H. TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin. Exp. Allergy 1995, 25:406-415.
27. Wilson S.J., Lau L., Howarth P.H. Inflammatory mediators in naturally occurring rhinitis. Clin. Exp. Allergy 1998, 28:220-227.
28. Ito K., Herbert C., Siegle J.S., Vuppusetty C., Hansbro N., Thomas P.S., Foster P.S., Barnes P.J., Kumar R.K. Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am. J. Respir. Cell Mol. Biol. 2008, 39:543-550.
29. Huang S.K., Zhang Q., Qiu Z., Chung K.F. Mechanistic impact of outdoor air pollution on asthma and allergic diseases. J. Thorac. Dis. 2015, 7:23-33.
30. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
31. Shakoory B., Fitzgerald S.M., Lee S.A., Chi D.S., Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J. Interferon Cytokine Res. 2004, 24:271-281.
32. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 1999, 274:27339-27342.